Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II profile picture

Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II

Is this your author profile? Create an account to claim and customize it!

Stand Alone

A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration
Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II — Books & Biography | Menrva Books